Moloney Securities Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $205K | Sell |
|
|||||
|
2024
Q3 | $230K | Sell |
|
|||||
|
2024
Q2 | $242K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $240K | Sell |
|
|||||
|
2021
Q3 | $273K | Hold |
|
|||||
|
2021
Q2 | $294K | Sell |
|
|||||
|
2021
Q1 | $296K | Sell |
|
|||||
|
2020
Q4 | $358K | Sell |
|
|||||
|
2020
Q3 | $525K | Sell |
|
|||||
|
2020
Q2 | $927K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $206K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $208K | Sell |
|
|||||
|
2019
Q1 | $223K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $226K | Hold |
|
|||||
|
2018
Q2 | $224K | Hold |
|
|||||
|
2018
Q1 | $207K | Sell |
|
|||||
|
2017
Q4 | $204K | Sell |
|
|||||
|
2017
Q3 | $280K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $244K | Buy |
|
|||||
|
2016
Q4 | $202K | Buy |
|